Last reviewed · How we verify
Classical Hodgkin lymphoma
Approved treatments
- Pembrolizuma · Memorial Sloan Kettering Cancer Center
- Opdivo · Bristol-Myers Squibb
Opdivo works by blocking the PD-1 receptor on immune cells, allowing them to attack cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Classical Hodgkin lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Classical Hodgkin lymphoma treatment landscape brief
- Classical Hodgkin lymphoma treatment updates RSS
Frequently asked questions about Classical Hodgkin lymphoma
What drugs treat Classical Hodgkin lymphoma?
Tracked treatments include Pembrolizuma, Opdivo.
What is the treatment for Classical Hodgkin lymphoma?
Standard treatment for Classical Hodgkin lymphoma includes Pembrolizuma, Opdivo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Classical Hodgkin lymphoma patent cliff · Classical Hodgkin lymphoma CI report
- Treatment: Pembrolizuma · Memorial Sloan Kettering Cancer Center
- Treatment: Opdivo · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing